Stock Rating Upgrade
The Value Trend Rating for United Therapeutics Corp (NASDAQ: UTHR) improved in recent days from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
United Therapeutics Corp (NASDAQ: UTHR) stock increased 1.5% on 4/8/24. The shares closed at $236.96. This advance was accompanied by normal trading volume. The stock has performed in line with the market over the last nine months and has risen 3.2% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, UTHR is expected to continue to be an important Value Builder.
United Therapeutics has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. The Value Trend Rating reflects inconsistent signals from PTR’s two proprietary measures of a stock’s attractiveness. United Therapeutics has a good Appreciation Score of 81 but a neutral Power Rating of 48, and the Positive Value Trend Rating results.
Be the first to comment